Archived Clinical Summary
Gestational Diabetes: Screening
Originally published on: January 14, 2014
This recommendation statement is currently archived and inactive. It should be used for historical purposes only. Click here for copyright and source information .
Disclaimer:Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Archived: Clinical Summary of a U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2008 recommendation of the U.S. Preventive Services Task Force (USPSTF) on screening for gestational diabetes mellitus. This summary is intended for use by primary care clinicians.
Select for copyright and source information.
|Population||Pregnant Women Who Have Not Previously Been Diagnosed With Diabetes|
No Recommendation due to insufficient evidence*
Women at increased risk of developing gestational diabetes mellitus (GDM) include those who:
|Rationale for No Recommendation||
The current evidence is insufficient to assess the balance between the benefits and harms of screening women for GDM either before or after 24 weeks gestation. Harms of screening include short-term anxiety in some women with positive screening results, and inconvenience to many women and medical practices because most positive screening tests are likely false-positives.
|Suggestions for Practice||
Until there is better evidence, clinicians should discuss screening for GDM with their patients and make case-by-case decisions. The discussion should include information about the uncertain benefits and harms as well as the frequency and uncertain meaning of a positive screening test result.
If a decision is made to screen for GDM:
Most screening is conducted between 24 and 28 weeks gestation. There is little evidence about the value of earlier screening.
|Other Approaches to Prevention||
Nearly all pregnant women should be encouraged to:
|*The current evidence is insufficient to establish the balance of benefits and harms for screening for gestational diabetes mellitus, either before or after 24 weeks gestation.|
Copyright and Source Information
This document is in the public domain within the United States.
Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.
AHRQ Publication No. 08-05115-EF-3
Internet Citation: Clinical Summary: Gestational Diabetes: Screening. U.S. Preventive Services Task Force. February 2014.